Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-01

FDA Approved: SYMPAZAN — Original Application (Aquestive Therapeutics)

View source ↗

Summary

The FDA approved SYMPAZAN (clobazam) via an Original Application from Aquestive Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SYMPAZAN (clobazam)

Snippet

ORIG AP for SYMPAZAN (CLOBAZAM)